Clinical Trial

ROLE OF FOLIC ACID IN THE MANAGEMENT OF ADJUVANT ENDOCRINE THERAPY-INDUCED HOT FLASHES IN BREAST CANCER PATIENTS

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated January 14, 2025 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
Summary
The study's objective is to investigate the role of folic acid administration in the management of hot flashes associated with adjuvant endocrine therapy in patients with breast cancer.
Trial Details
NCT Number NCT06774885
Lead Sponsor Future University in Egypt
Conditions THERAPY-INDUCED HOT FLASHES IN BREAST CANCER PATIENTS
Enrollment 120 participants
Start Date 2025-02-09
Primary Completion 2025-08 (estimated)
Study Completion 2025-08 (estimated)
Updated on ClinicalTrials.gov 2025-01-14